|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen
|
Bruce V. Bigelow |
02/10/12 |
San Diego
|
|
Four Themes to Watch in Personalized Medicine
|
Jonathan Sheffi |
01/30/12 |
San Francisco
|
|
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More
|
Bruce V. Bigelow |
01/26/12 |
San Diego
|
|
Roche Makes $5.7B Hostile Takeover Bid for Illumina
|
Luke Timmerman |
01/25/12 |
San Diego
|
|
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More
|
Bruce V. Bigelow |
01/12/12 |
San Diego
|
|
PacBio CEO Hugh Martin Resigns, Being Replaced by Mike Hunkapiller
|
Luke Timmerman |
01/06/12 |
San Francisco
|
|
The Top 10 Traffic-Getting Stories at Xconomy San Diego
|
Bruce V. Bigelow |
12/28/11 |
San Diego
|
|
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO
|
Luke Timmerman |
12/14/11 |
San Diego
|
|
Spiral Genetics, Started by UW Classmates, Looks to Crunch DNA Data in New Way
|
Luke Timmerman |
11/30/11 |
Seattle
|
|
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics
|
Luke Timmerman |
11/07/11 |
Seattle
|
|
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center
|
Arlene Weintraub |
11/03/11 |
New York
|
|
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
11/03/11 |
San Diego
|
|
PacBio Posts Flat Revenues in Q3, Names Mike Hunkapiller New Executive Chairman
|
Luke Timmerman |
10/27/11 |
San Francisco
|
|
Agradis Takes Root, Illumina Cuts Back, Verenium Arranges Financing, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
10/27/11 |
San Diego
|
|
Illumina To Cut 200 Jobs, 8 Percent of Workforce, After Third Quarter Sales Fall Short
|
Luke Timmerman |
10/25/11 |
San Diego
|
|
Illumina Takes Page From Apple Playbook, in Blending Hardware and Software for the Genome
|
Luke Timmerman |
10/20/11 |
San Francisco
|
|
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
10/20/11 |
San Diego
|
|
Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload
|
Luke Timmerman |
10/20/11 |
Seattle
|
|
DNAnexus, With Google Ventures and TPG’s Cash, Seeks Edge in $100B Genome Computing Market
|
Luke Timmerman |
10/19/11 |
San Francisco
|
|
Sequenom Inaugurates New Diagnostic Test for Down Syndrome
|
Bruce V. Bigelow |
10/17/11 |
San Diego
|
|
Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again
|
Luke Timmerman |
10/17/11 |
National
|
|
Sequenom Plans $19M Lab in North Carolina, Illumina Shares Plunge, PatientSafe Advances Device, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
10/13/11 |
San Diego
|
|
Illumina Stock Dives on Weak Quarterly Sales Report
|
Luke Timmerman |
10/07/11 |
San Diego
|
|
When Will Software for the Genome Take Off? Find out Oct. 24
|
Luke Timmerman |
10/07/11 |
San Francisco
|
|
Knome Moves Beyond the Mega-Rich With Genome Analysis Service
|
Luke Timmerman |
09/29/11 |
Boston
|
|
New York Life Sciences 2031: OrbiMed’s Sam Isaly on Genomics, Health Reform, and Biotech’s Future
|
Arlene Weintraub |
09/22/11 |
New York
|
|
Ion Torrent’s Fast and Cheap DNA Sequencer Catches On, Even as Biologists Tighten Belts
|
Luke Timmerman |
09/15/11 |
National
|
|
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/18/11 |
San Diego
|
|
Complete Genomics Stock Falls on Sales Decline, as Sequencing Gets Cheaper
|
Luke Timmerman |
08/04/11 |
San Francisco
|
|
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/04/11 |
San Diego
|
|
Page 1 of
6 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.